Name: Staphylococcus aureus 209 P
Creator: BacDive
License: http://creativecommons.org/licenses/by-nc/4.0/

Strain identifier

BacDive ID: 14445

Type strain:

Species: Staphylococcus aureus

Strain Designation: 209 P, 209P

Culture col. no.: CCUG 1828, CCM 2022, DSM 346, ATCC 6538P, CIP 53.156, NCTC 7447, WDCM 00033, JCM 2151, BCRC 10451, CECT 240, CGMCC 1.2910, FDA 209P, IAM 1011, IAM 12082, IFO 12732, IID 671, KCTC 1927, LMG 8195, NBRC 12732, NCFB 1963, NCIMB 8625, NRIC 1136, NRRL B-313, RIMD 3109007, IMET 10904, NCDO 1963, NRRL : B-313, IFO 3061, WDCM 00195

Strain history: CIP <- 1953, ATCC <- W.A. Randall, FDA, Washington, USA: strain 209P

NCBI tax ID(s): 1280 (species)

SI-ID 4992

LMG 8195, CCM 2022, CCUG 1828, CECT 240, IAM 1011, IAM 12082, IFO 12732, IFO 3061, IMET 10904, NCIB 8625, NCTC 7447, NCDO 1963, JCM 2151, CCRC 10451, KCTC 1927, NCIMB 8625, ICMP 5926, CIP 53.156, LMD 72.46, NCFB 1963, KCTC 1916, KCTC 1947, NBRC 12732, NCCB 72046, BCRC 10451, NBRC 100909, CCT 0139, CCT 2564, CCT 3025, CIP 53156, KACC 10778, NBIMCC 509, NCAIM B.01755, NCIM 2079, CDBB 1006, ACM 110, ACM 2788, CNCTC 5479, CGMCC 1.1861, CGMCC 1.2155, VTT E-96698, VTT E-062629, NRRL B-313, DSM 346

Other strains from Staphylococcus aureus

Section

Staphylococcus aureus 209 P is a facultative anaerobe, mesophilic, Gram-positive human pathogen that has multiple antibiotic resistances.

antibiotic resistance
Gram-positive
facultative anaerobe
human pathogen
mesophilic
16S sequence
Bacteria
genome sequence

Information on the name and the taxonomic classification. Name and taxonomic classification

	Last LPSN update	14-12-2023 (DD-MM-YYYY)
	Domain	"Bacteria"
	Phylum	*Bacillota*
	Class	*Bacilli*
	Order	*Caryophanales*
	Family	*Staphylococcaceae*
	Genus	*Staphylococcus*
	Species	**Staphylococcus aureus**
	Full Scientific Name (LPSN)	Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980)

Synonym

Staphylococcus aureus subsp. anaerobius

Information on morphological and physiological properties Morphology

[Ref.: #116632]	Gram stain	positive
[Ref.: #69480]	Gram stain	positive Confidence in %100

[Ref.: #116632]	Cell shape	coccus-shaped

[Ref.: #116632]	Motility	no

[Ref.: #139]	Type of hemolysis	beta
[Ref.: #139]	Hemolysis ability	1
[Ref.: #139]	Incubation period	1-2 days

[Ref.: #116632]	Hemolysis ability	1

Information on culture and growth conditions Culture and growth conditions

[Ref.: #139]

Culture medium

COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)

[Ref.: #139]

Culture medium growth

[Ref.: #139]

Culture medium link

Medium recipe at MediaDive

[Ref.: #139]

Culture medium composition

expand / minimize

[Ref.: #139]

Culture medium

TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)

[Ref.: #139]

Culture medium growth

[Ref.: #139]

Culture medium link

Medium recipe at MediaDive

[Ref.: #139]

Culture medium composition

expand / minimize

[Ref.: #41865]

Culture medium

MEDIUM 3 - Columbia agar

[Ref.: #41865]

Culture medium growth

[Ref.: #41865]

Culture medium composition

expand / minimize

[Ref.: #116632]

Culture medium

CIP Medium 72

[Ref.: #116632]

Culture medium growth

[Ref.: #116632]

Culture medium link

Medium recipe provided by DSMZ

[Ref.: #116632]

Culture medium

CIP Medium 3

[Ref.: #116632]

Culture medium growth

[Ref.: #116632]

Culture medium link

Medium recipe provided by DSMZ

	Kind of temperature		Temperature
[Ref.: #139]		growth	37 °C
[Ref.: #41865]		growth	37 °C
[Ref.: #67770]		growth	37 °C
[Ref.: #116632]		growth	15-45 °C
[Ref.: #116632]	no	growth	10 °C

[Ref.: #139]	Temperature range	mesophilic
[Ref.: #41865]	Temperature range	mesophilic
[Ref.: #67770]	Temperature range	mesophilic
[Ref.: #116632]	Temperature range	psychrophilic

Information on physiology and metabolism Physiology and metabolism

[Ref.: #116632]

Oxygen tolerance

facultative anaerobe

Note that the displayed test results represent raw data and therefore may deviate!

Antibiotic susceptibility testing

Test 1

Test 2

Test 3

Test 4

Test 5

Test 6

Test 7

Test 8

Reference

[Ref.: #139]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
40
32-34
36-38
42-44
34
40
40
28
resistant0
50
32-34
30
22
24
20
30
30
28
22-24
resistant0
8
24
18
8
26
20
34
28
38
36-38
32
30
resistant0
30
20
32-34

[Ref.: #139]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
40-42
34
38-40
42-44
32-34
40-42
40
30
resistant0
50
34
30
26
28
20
32
30
30
24-26
resistant0
10
24-26
18-20
8
28-30
24
36
28-30
38-40
30-32
32
32
resistant0
28-30
20
32-34

[Ref.: #139]
Mueller-Hinton Agar
37
1
aerob
yes
Inhibition zone diameter in mm
44
34-36
40
46
36
44
42-44
34
resistant0
50
36-38
30
26-28
28
20
32-34
30
30
26
resistant0
10
26
18
10
30
24
38
30
40
38-40
34-36
40
resistant0
32
20
36

[Ref.: #139]
Mueller-Hinton Agar
37
1
aerob
yes
Inhibition zone diameter in mm
42-44
36
40
48
36
44
42
30
resistant0
50
38
32
26
26-28
20
32
30-32
30
24-26
resistant0
10
26
20
8
28-30
22
38-40
30
40
38-40
34
40
resistant0
30
20
38

[Ref.: #139]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
28
24
24
32
22
28
26-28
18-20
resistant0
38
18
16-18
16
20
14
18
18
18
18
resistant0
resistant0
18
12
resistant0
resistant0
resistant0
18
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #139]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
40-42
34
36-38
42-44
32
40
40
28
resistant0
50
32-34
30-32
26
26
20
30-32
28-30
28
24
resistant0
12
24
18-20
10
34
22
36
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #139]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
42
34
38-40
42-44
32-34
40-42
38-40
28
resistant0
46
32
30-32
24
24
20-22
30-32
28-30
28-30
24-26
resistant0
10
24
16-18
10
28
22
34-36
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #139]
Mueller Hinton
37

aerob
yes
Inhibition zone diameter in mm
42-44
36
40
48
34-36
42-44
40
28
resistant0
50
36-38
32
26
26
20-22
32
30
30
26
resistant0
8
26
20
8
30
22
38-40
30
40
40-42
36
38
resistant0
30
20
36

Only first 15 entries are displayed. Click here to see all.

[Ref.: #69481]	Ability of spore formation	no Confidence in %99
[Ref.: #69480]	Ability of spore formation	no Confidence in %99.725

	Metabolite	Utilization activity	Kind of utilization tested
[Ref.: #68375]	arabinose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68375]	arginine ChEBI	+	hydrolysis	* from API ID32STA
[Ref.: #68375]	cellobiose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68375]	D-fructose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	D-glucose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	D-mannitol ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	D-mannose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	esculin ChEBI	-	hydrolysis	* from API ID32STA
[Ref.: #68375]	maltose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	N-acetylglucosamine ChEBI	+	fermentation	* from API ID32STA
[Ref.: #116632]	nitrate ChEBI	+	reduction
[Ref.: #68375]	nitrate ChEBI	+	reduction	* from API ID32STA
[Ref.: #116632]	nitrite ChEBI	-	reduction
[Ref.: #68375]	ornithine ChEBI	-	degradation	* from API ID32STA
[Ref.: #68375]	raffinose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68375]	sucrose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	trehalose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #116632]	tributyrin ChEBI	+	hydrolysis
[Ref.: #68375]	turanose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68375]	urea ChEBI	+	hydrolysis	* from API ID32STA
	Only first 10 entries are displayed. Click here to see all.

	Metabolite production	Metabolite	Production
[Ref.: #116632]		indole ChEBI	no
[Ref.: #68375]		acetoin ChEBI	yes	* from API ID32STA

	Physiological tests	Metabolite	Voges-Proskauer-test
[Ref.: #116632]		acetoin ChEBI	+
[Ref.: #68375]		acetoin ChEBI	+	* from API ID32STA

	Enzyme	Enzyme activity	EC number
[Ref.: #68382]	acid phosphatase	+	3.1.3.2	* from API zym
[Ref.: #116632]	alcohol dehydrogenase	+	1.1.1.1
[Ref.: #68375]	alkaline phosphatase	+	3.1.3.1	* from API ID32STA, API zym
[Ref.: #68382]	alpha-chymotrypsin	-	3.4.21.1	* from API zym
[Ref.: #68382]	alpha-fucosidase	-	3.2.1.51	* from API zym
[Ref.: #68382]	alpha-galactosidase	-	3.2.1.22	* from API zym
[Ref.: #68382]	alpha-glucosidase	+	3.2.1.20	* from API zym
[Ref.: #68382]	alpha-mannosidase	-	3.2.1.24	* from API zym
[Ref.: #68375]	arginine dihydrolase	+	3.5.3.6	* from API ID32STA
[Ref.: #116632]	beta-galactosidase	+	3.2.1.23
[Ref.: #68375]	beta-galactosidase	-	3.2.1.23	* from API ID32STA, API zym
[Ref.: #68375]	beta-glucosidase	-	3.2.1.21	* from API ID32STA, API zym
[Ref.: #68375]	beta-glucuronidase	-	3.2.1.31	* from API ID32STA, API zym
[Ref.: #139]	catalase	+	1.11.1.6
[Ref.: #116632]	catalase	+	1.11.1.6
[Ref.: #116632]	coagulase	+
[Ref.: #68382]	cystine arylamidase	+	3.4.11.3	* from API zym
[Ref.: #139]	cytochrome-c oxidase	-	1.9.3.1
[Ref.: #116632]	DNase	+
[Ref.: #68382]	esterase (C 4)	+		* from API zym
[Ref.: #68382]	esterase lipase (C 8)	+		* from API zym
[Ref.: #116632]	gelatinase	-
[Ref.: #68375]	L-arginine arylamidase	-		* from API ID32STA
[Ref.: #116632]	lecithinase	-
[Ref.: #68382]	leucine arylamidase	-	3.4.11.1	* from API zym
[Ref.: #116632]	lipase	-
[Ref.: #68382]	lipase (C 14)	-		* from API zym
[Ref.: #116632]	lysine decarboxylase	-	4.1.1.18
[Ref.: #68382]	N-acetyl-beta-glucosaminidase	-	3.2.1.52	* from API zym
[Ref.: #68382]	naphthol-AS-BI-phosphohydrolase	+		* from API zym
[Ref.: #116632]	ornithine decarboxylase	-	4.1.1.17
[Ref.: #68375]	ornithine decarboxylase	-	4.1.1.17	* from API ID32STA
[Ref.: #116632]	oxidase	-
[Ref.: #116632]	protease	+
[Ref.: #68382]	trypsin	-	3.4.21.4	* from API zym
[Ref.: #116632]	urease	+	3.5.1.5
[Ref.: #68375]	urease	+	3.5.1.5	* from API ID32STA
[Ref.: #68382]	valine arylamidase	-		* from API zym
	Only first 10 entries are displayed. Click here to see all.

API® Biotype100:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	ControlQ	D-glucose as carbon sourceGLU	D-fructose as carbon sourceFRU	D-galactose as carbon sourceGAL	D-trehalose as carbon sourceTRE	D-mannose as carbon sourceMNE	L-sorbose as carbon sourceSBE	D-melibiose as carbon sourceMEL	sucrose as carbon sourceSAC	D-raffinose as carbon sourceRAF	maltotriose as carbon sourceMTE	maltose as carbon sourceMAL	lactose as carbon sourceLAC	lactulose as carbon sourceLTE	1-O-methyl-beta-galactopyranoside as carbon sourceMbGa	1-O-methyl-alpha-galactopyranoside as carbon sourceMaGa	D-cellobiose as carbon sourceCEL	gentiobiose as carbon sourceGEN	1-O-methyl-beta-D-glucopyranoside as carbon sourceMbGu	esculin as carbon sourceESC	D-ribose as carbon sourceRIB	L-arabinose as carbon sourceARA	D-xylose as carbon sourceXYL	palatinose as carbon sourcePLE	L-rhamnose as carbon sourceRHA	L-fucose as carbon sourceFUC	D-melezitose as carbon sourceMLZ	D-arabitol as carbon sourceDARL	L-arabitol as carbon sourceLARL	xylitol as carbon sourceXLT	dulcitol as carbon sourceDUL	D-tagatose as carbon sourceTAG	glycerol as carbon sourceGLY	myo-inositol as carbon sourceINO	D-mannitol as carbon sourceMAN	maltitol as carbon sourceMTL	D-turanose as carbon sourceTUR	D-sorbitol as carbon sourceSOR	adonitol as carbon sourceADO	hydroxyquinoline-beta-glucuronide as carbon sourceHBG	D-lyxose as carbon sourceLYX	i-erythritol as carbon sourceERY	1-O-methyl-alpha-D-glucoside as carbon sourceMDG	3-O-methyl-D-glucose as carbon source3MDG	D-saccharate as carbon sourceSAT	mucate as carbon sourceMUC	L-tartrate as carbon sourceLTAT	D-tartrate as carbon sourceDTAT	meso-tartrate as carbon sourceMTAT	D-malate as carbon sourceDMLT	L-malate as carbon sourceLMLT	cis-aconitate as carbon sourceCATE	trans-aconitate as carbon sourceTATE	tricarballylate as carbon sourceTTE	citrate as carbon sourceCIT	D-glucuronate as carbon sourceGRT	D-galacturonate as carbon sourceGAT	2-ketogluconate as carbon source2KG	5-ketogluconate as carbon source5KG	tryptophan as carbon sourceTRY	N-acetyl-D-glucosamine as carbon sourceNAG	D-gluconate as carbon sourceGNT	phenylacetate as carbon sourcePAC	protocatechuate as carbon sourcePAT	4-hydroxybenzoate as carbon sourcepOBE	quinate as carbon sourceQAT	gentisate as carbon sourceGTE	3-hydroxybenzoate as carbon sourcemOBE	benzoate as carbon sourceBAT	3-phenylpropionate as carbon sourcePPAT	m-coumarate as carbon sourceCMT	trigonelline as carbon sourceTGE	betaine as carbon sourceBET	putrescine as carbon sourcePCE	4-aminobutyrate as carbon sourceABT	histamine as carbon sourceHIN	DL-lactate as carbon sourceLAT	caprate as carbon sourceCAP	caprylate as carbon sourceCYT	L-histidine as carbon sourceHIS	succinate as carbon sourceSUC	fumarate as carbon sourceFUM	glutarate as carbon sourceGRE	DL-glycerate as carbon sourceGYT	5-aminovalerate as carbon sourceAVT	ethanolamine as carbon sourceETN	tryptamine as carbon sourceTTN	D-glucosamine as carbon sourceGLN	itaconate as carbon sourceITA	3-hydroxybutyrate as carbon source3OBU	L-aspartate as carbon sourceAPT	L-glutamate as carbon sourceGTT	L-proline as carbon sourcePRO	D-alanine as carbon sourceDALA	L-alanine as carbon sourceLALA	L-serine as carbon sourceSER	malonate as carbon sourceMNT	propionate as carbon sourcePROP	L-tyrosine as carbon sourceTYR	2-ketoglutarate as carbon source2KT
[Ref.: #116632]	3018	not determinedn.d.	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

API® ID32STA:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Urease/urea hydrolysisURE	Arginine dihydrolaseADH (Arg)	Ornithine decarboxylaseODC	Esculin hydrolysisESC	Fermentation of D-glucoseGLU	Fermentation of D-fructoseFRU	Fermentation of D-mannoseMNE	Fermentation of maltoseMAL	Fermentation of lactoseLAC	Fermentation of trehaloseTRE	Fermentation of D-mannitolMAN	Fermentation of raffinoseRAF	Fermentation of D-riboseRIB	Fermentation of cellobioseCEL	Reduction of nitrateNIT	Acetoin production (Voges Proskauer test)VP	beta-Galactosidasebeta GAL	L-arginine arylamidaseArgA	Alkaline phosphatasePAL	Pyrrolidonyl arylamidasePyrA	Novobiocin resistanceNOVO	Fermentation of sucroseSAC	Fermentation of N-acetyl-glucosamineNAG	Fermentation of turanoseTUR	Fermentation of arabinoseARA	beta-Glucuronidasebeta GUR
[Ref.: #139]	6275	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+	+/-	+	+	-	-	-
[Ref.: #139]	5756	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
[Ref.: #139]	5757	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	-	+	+	+	-	-	-
[Ref.: #139]	5758	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	+	+	+	+	-	-	-
[Ref.: #139]	5759	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
[Ref.: #139]	5760	+	+	-	-	+	+	+	+	+/-	+	+	-	+/-	-	+	+	-	-	+	+	-	+	+	-	-	-
[Ref.: #139]	5761	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
[Ref.: #139]	5762	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
[Ref.: #139]	6215	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	+	+/-	+	+	-	-	-
[Ref.: #139]	6356	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	+	+	+	+	-	-	-

API® zym:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Control	2-naphthyl phosphateAlkaline phosphatase	2-naphthyl butyrateEsterase (C 4)	2-naphtyl caprylateEsterase Lipase (C 8)	2-naphthyl myristateLipase (C 14)	L-leucyl-2-naphthylamideLeucine arylamidase	L-valyl-2-naphthylamideValine arylamidase	L-cystyl-2-naphthylamideCystine arylamidase	N-benzoyl-DL-arginine-2-naphthylamideTrypsin	N-glutaryl-phenylalanine-2-naphthylamidealpha- Chymotrypsin	2-naphthyl phosphateAcid phosphatase	Naphthol-AS-BI-phosphateNaphthol-AS-BI-phosphohydrolase	6-Br-2-naphthyl-alphaD-galactpyranosidealpha- Galactosidase	2-naphthyl-betaD-galactpyranosidebeta- Galactosidase	Naphthol-AS-BI-betaD-glucuronidebeta- Glucuronidase	2-naphthyl-alphaD-glucopyranosidealpha- Glucosidase	6-Br-2-naphthyl-betaD-glucopyranosidebeta- Glucosidase	1-naphthyl-N-acetyl-betaD-glucosaminideN-acetyl-beta- glucosaminidase	6-Br-2-naphthyl-alphaD-mannopyranosidealpha- Mannosidase	2-naphthyl-alphaL-fucopyranosidealpha- Fucosidase
[Ref.: #116632]	12707	-	+	+	+	-	-	-	+	-	-	+	+	-	-	-	+	-	-	-	-

Information on isolation source, the sampling and environmental conditions Isolation, sampling and environmental information

[Ref.: #69479]

Global distribution of 16S sequence AB598746 (>99% sequence identity) for Staphylococcus from Microbeatlas

Aquatic Samples	991
Soil Samples	353
Animal Samples	21663
Plant Samples	192
Total Samples	23199

Information on possible application of the strain and its possible interaction with e.g. potential hosts Safety information

[Ref.: #139]	Pathogenicity (human)	yes
[Ref.: #139]	Pathogenicity (animal)	yes
[Ref.: #139]	Biosafety level	2	Risk group (German classification) According to TRBA 466
[Ref.: #116632]	Biosafety level	2	Risk group (French classification)

Information on genomic background e.g. entries in nucleic sequence databass Sequence information

16S Sequence information:

	Sequence accession description	Seq. accession number	Sequence length (bp)	Sequence database	Associated NCBI tax ID
[Ref.: #67770]	Staphylococcus aureus NBRC 12732 gene for 16S rRNA, partial sequence	AB680336	1477	ENA	1280 tax ID
[Ref.: #67770]	Staphylococcus aureus JCM 2151 gene for 16S rRNA, partial sequence	AB598746	1474	ENA	1280 tax ID

Genome sequence information:

	Sequence accession description	Seq. accession number	Assembly level	Sequence database	Associated NCBI tax ID
[Ref.: #66792]	Staphylococcus aureus NCTC7447	GCA_900457305	contig	GenBank	1280 tax ID	*
[Ref.: #66792]	Staphylococcus aureus subsp. aureus JCM 2151	GCA_001312225	contig	GenBank	1295139 tax ID	*
[Ref.: #66792]	Staphylococcus aureus strain NCTC7447	1280.18033	wgs	PATRIC	1280 tax ID	*
[Ref.: #66792]	Staphylococcus aureus subsp. aureus JCM 2151	1295139.3	wgs	PATRIC	1295139 tax ID	*
[Ref.: #66792]	Staphylococcus aureus aureus JCM 2151	2728369715	draft	JGI IMG/M	1295139 tax ID	*

Data predicted using genome information as a basis Genome-based predictions

	Trait	Prediction	Confidence in %	In training data
	Predictions from GenomeNet Sporulation v. 1 based on: Staphylococcus aureus subsp. aureus JCM 2151 PATRIC: 1295139.3
[Ref.: #69481]	spore-forming	no	99	no

	Trait	Prediction	Confidence in %	In training data
	Predictions from Diaspora project based on: Staphylococcus aureus strain NCTC7447 PATRIC: 1280.18033
[Ref.: #69480]	motile	no	89.088	no
[Ref.: #69480]	gram-positive	yes	88.247	no
[Ref.: #69480]	anaerobic	no	99.434	no
[Ref.: #69480]	aerobic	yes	87.725	no
[Ref.: #69480]	halophile	yes	94.092	no
[Ref.: #69480]	spore-forming	no	93.725	no
[Ref.: #69480]	thermophile	no	99.655	no
[Ref.: #69480]	glucose-util	yes	87.124	no
[Ref.: #69480]	flagellated	no	90.975	no
[Ref.: #69480]	glucose-ferment	yes	87.226	no

Availability in culture collections External links

[Ref.: #139]

Culture collection no.

CCUG 1828, CCM 2022, DSM 346, ATCC 6538P, CIP 53.156, NCTC 7447, WDCM 00033, JCM 2151, BCRC 10451, CECT 240, CGMCC 1.2910, FDA 209P, IAM 1011, IAM 12082, IFO 12732, IID 671, KCTC 1927, LMG 8195, NBRC 12732, NCFB 1963, NCIMB 8625, NRIC 1136, NRRL B-313, RIMD 3109007, IMET 10904, NCDO 1963, NRRL : B-313, IFO 3061, WDCM 00195

[Ref.: #83588]

SI-ID 4992

Literature:

Only first 10 entries are displayed. Click here to see all.

	Title	Authors	Journal	DOI	Year
Pathogenicity	Saccharobisindole, Neoasterric Methyl Ester, and 7-Chloro-4(1H)-quinolone: Three New Compounds Isolated from the Marine Bacterium Saccharomonospora sp.	Kim S, Le TC, Han SA, Hillman PF, Hong A, Hwang S, Du YE, Kim H, Oh DC, Cha SS, Lee J, Nam SJ, Fenical W	Mar Drugs	10.3390/md20010035	2021	*
Pathogenicity	Characterization and validation of an alternative reference bacterium Korean Pharmacopoeia Staphylococcus aureus strain.	An YW, Choi YS, Yun MR, Choi C, Kim SY	J Microbiol	10.1007/s12275-022-1335-5	2022	*
Pathogenicity	Preparation, Antimicrobial Properties, and Cytotoxicity of Acrylic Resins Containing Poly(diallyldimethylammonium chloride).	Dos Santos RLO, Sarra G, Lincopan N, Petri DFS, Aliaga J, Marques MM, Dias RB, Coto NP, Sugaya NN, Paula CR	Int J Prosthodont	10.11607/ijp.6506	2020	*
Pathogenicity	Potent Antibacterial Activity of Synthetic Peptides Designed from Salusin-beta and HIV-1 Tat(49-57).	Kimura M, Kosuge K, Ko Y, Kurosaki N, Tagawa N, Kato I, Uchida Y	Chem Pharm Bull (Tokyo)	10.1248/cpb.c20-00209	2020	*
Pathogenicity	The Antimicrobial and Antiviral Activity of Polyphenols from Almond (Prunus dulcis L.) Skin.	Musarra-Pizzo M, Ginestra G, Smeriglio A, Pennisi R, Sciortino MT, Mandalari G	Nutrients	10.3390/nu11102355	2019	*
Pathogenicity	Comparative In Vitro Evaluation of Antibacterial and Osteogenic Activity of Polysaccharide and Flavonoid Fractions Isolated from the leaves of Saussurea controversa.	Khlusov I, Avdeeva E, Shupletsova V, Khaziakhmatova O, Litvinova L, Porokhova E, Reshetov Y, Zvereva I, Mushtovatova L, Karpova M, Guryev A, Sukhodolo I, Belousov M	Molecules	10.3390/molecules24203680	2019	*
Pathogenicity	Evaluating antimicrobial and antioxidant capacity of endemic Phlomis russeliana from Turkey and its antiproliferative effect on Human Caco-2 Cell Lines.	Alpay M, Dulger G, Sahin IE, Dulger B	An Acad Bras Cienc	10.1590/0001-3765201920180404	2019	*
Pathogenicity	Antibacterial Effects of Phytic Acid against Foodborne Pathogens and Investigation of Its Mode of Action.	Zhou QI, Zhao YU, Dang H, Tang Y, Zhang B	J Food Prot	10.4315/0362-028X.JFP-18-418	2019	*
Metabolism	Study of the Lipid Profile of ATCC and Clinical Strains of Staphylococcus aureus in Relation to Their Antibiotic Resistance.	Bisignano C, Ginestra G, Smeriglio A, La Camera E, Crisafi G, Franchina FA, Tranchida PQ, Alibrandi A, Trombetta D, Mondello L, Mandalari G	Molecules	10.3390/molecules24071276	2019	*
Phylogeny	Genetic and Transcriptomic Analyses of Ciprofloxacin-Tolerant Staphylococcus aureus Isolated by the Replica Plating Tolerance Isolation System (REPTIS).	Matsuo M, Hiramatsu M, Singh M, Sasaki T, Hishinuma T, Yamamoto N, Morimoto Y, Kirikae T, Hiramatsu K	Antimicrob Agents Chemother	10.1128/AAC.02019-18	2019	*
Pathogenicity	Chemical constituents, in vitro antioxidant and antimicrobial properties of ethyl acetate extract obtained from Cytisus triflorus l'Her.	Benabderrahmane W, Amrani A, Benaissa O, Lores M, Lamas JP, de Miguel T, Benayache F, Benayache S	Nat Prod Res	10.1080/14786419.2018.1519816	2018	*
Pathogenicity	Lipid transfer protein isolated from noni seeds displays antibacterial activity in vitro and improves survival in lethal sepsis induced by CLP in mice.	Souza AA, Costa AS, Campos DCO, Batista AHM, Sales GWP, Nogueira NAP, Alves KMM, Coelho-de-Souza AN, Oliveira HD	Biochimie	10.1016/j.biochi.2018.03.011	2018	*
Pathogenicity	In Vitro Tolerance of Drug-Naive Staphylococcus aureus Strain FDA209P to Vancomycin.	Singh M, Matsuo M, Sasaki T, Morimoto Y, Hishinuma T, Hiramatsu K	Antimicrob Agents Chemother	10.1128/AAC.01154-16	2017	*
Pathogenicity	Antimicrobial and anti-Quorum Sensing activities of selected medicinal plants of Ethiopia: Implication for development of potent antimicrobial agents.	Bacha K, Tariku Y, Gebreyesus F, Zerihun S, Mohammed A, Weiland-Brauer N, Schmitz RA, Mulat M	BMC Microbiol	10.1186/s12866-016-0765-9	2016	*
Pathogenicity	Laxitextines A and B, Cyathane Xylosides from the Tropical Fungus Laxitextum incrustatum.	Mudalungu CM, Richter C, Wittstein K, Abdalla MA, Matasyoh JC, Stadler M, Sussmuth RD	J Nat Prod	10.1021/acs.jnatprod.5b00950	2016	*
Phylogeny	[Identification and Antagonistic Properties of the Soil Streptomycete Streptomyces sp. 100].	Biliavska LA, Efimenko TA, Efremenkova OV, Koziritska VY, Iutynska GA	Mikrobiol Z		2016	*
Biotechnology	In Vitro Antimicrobial Activity and Effect on Biofilm Production of a White Grape Juice (Vitis vinifera) Extract.	Filocamo A, Bisignano C, Mandalari G, Navarra M	Evid Based Complement Alternat Med	10.1155/2015/856243	2015	*
Pathogenicity	Green synthesis of silver nanoparticles using cranberry powder aqueous extract: characterization and antimicrobial properties.	Ashour AA, Raafat D, El-Gowelli HM, El-Kamel AH	Int J Nanomedicine	10.2147/IJN.S87268	2015	*
Genetics	Complete Genome Sequence of the Drug-Naive Classical Staphylococcus aureus Strain FDA209P.	Singh M, Sasaki T, Matsuo M, Morimoto Y, Aiba Y, Hiramatsu K	Genome Announc	10.1128/genomeA.01343-15	2015	*
Pathogenicity	TLR2 activation in corneal stromal cells by Staphylococcus aureus-induced keratitis.	Marino A, Pergolizzi S, Lauriano ER, Santoro G, Spataro F, Cimino F, Speciale A, Nostro A, Bisignano G	APMIS	10.1111/apm.12333	2014	*
Pathogenicity	Antibacterial performance of ZnO-based fillers with mesoscale structured morphology in model medical PVC composites.	Machovsky M, Kuritka I, Bazant P, Vesela D, Saha P	Mater Sci Eng C Mater Biol Appl	10.1016/j.msec.2014.04.034	2014	*
Pathogenicity	Salusin-beta, an antimicrobially active peptide against Gram-positive bacteria.	Kimura M, Shindo M, Moriizumi T, Tagawa N, Fujinami A, Kato I, Uchida Y	Chem Pharm Bull (Tokyo)	10.1248/cpb.c14-00103	2014	*
Pathogenicity	Antimicrobial effect of Dinoponera quadriceps (Hymenoptera: Formicidae) venom against Staphylococcus aureus strains.	Lima DB, Torres AF, Mello CP, de Menezes RR, Sampaio TL, Canuto JA, da Silva JJ, Freire VN, Quinet YP, Havt A, Monteiro HS, Nogueira NA, Martins AM	J Appl Microbiol	10.1111/jam.12548	2014	*
Pathogenicity	Evaluation of antibacterial and cytotoxic effects of nano-sized bioactive glass/collagen composites releasing tetracycline hydrochloride.	Rivadeneira J, Di Virgilio AL, Audisio MC, Boccaccini AR, Gorustovich AA	J Appl Microbiol	10.1111/jam.12476	2014	*
Pathogenicity	Synthesis, characterization, crystal structure determination and biological screening of novel N-1 and C5 alkyl substituted scaffolds of pyrimidine.	Pathan NB, Parvez A, Bader A, Shaheen U, Hadda TB	Eur J Med Chem	10.1016/j.ejmech.2013.12.036	2014	*
Pathogenicity	Developing a microbiological growth inhibition screening assay for the detection of 27 veterinary drugs from 13 different classes in animal feedingstuffs.	Bohn T, Pellet T, Boscher A, Hoffmann L	Food Addit Contam Part A Chem Anal Control Expo Risk Assess	10.1080/19440049.2013.832400	2013	*
Pathogenicity	Antimicrobial activity of quinoxaline 1,4-dioxide with 2- and 3-substituted derivatives.	Vieira M, Pinheiro C, Fernandes R, Noronha JP, Prudencio C	Microbiol Res	10.1016/j.micres.2013.06.015	2013	*
Pathogenicity	Enhanced photoinactivation of Staphylococcus aureus with nanocomposites containing plasmonic particles and hematoporphyrin.	Khlebtsov BN, Tuchina ES, Khanadeev VA, Panfilova EV, Petrov PO, Tuchin VV, Khlebtsov NG	J Biophotonics	10.1002/jbio.201200079	2012	*
Pathogenicity	A concise synthesis and antimicrobial activities of 3-polyamino-23,24-bisnorcholanes as steroid-polyamine conjugates.	Kim HS, Khan SN, Jadhav JR, Jeong JW, Jung K, Kwak JH	Bioorg Med Chem Lett	10.1016/j.bmcl.2011.05.048	2011	*
Metabolism	Antibacterial effect of silver nanoparticles on Staphylococcus aureus.	Li WR, Xie XB, Shi QS, Duan SS, Ouyang YS, Chen YB	Biometals	10.1007/s10534-010-9381-6	2010	*
Pathogenicity	Antimicrobial activities of 1,4-benzoquinones and wheat germ extract.	Kim MH, Jo SH, Ha KS, Song JH, Jang HD, Kwon YI	J Microbiol Biotechnol	10.4014/jmb.1004.04037	2010	*
Pathogenicity	Antibacterial activity of 5-dialkylaminomethylhydantoins and related compounds.	Fujisaki F, Shoji K, Shimodouzono M, Kashige N, Miake F, Sumoto K	Chem Pharm Bull (Tokyo)	10.1248/cpb.58.1123	2010	*
Pathogenicity	In vitro effect of branch extracts of Juniperus species from Turkey on Staphylococcus aureus biofilm.	Marino A, Bellinghieri V, Nostro A, Miceli N, Taviano MF, Guvenc A, Bisignano G	FEMS Immunol Med Microbiol	10.1111/j.1574-695X.2010.00705.x	2010	*
Pathogenicity	Direct observation and analysis of bacterial growth on an antimicrobial surface.	Yamada H, Takahashi N, Okuda S, Tsuchiya Y, Morisaki H	Appl Environ Microbiol	10.1128/AEM.00576-10	2010	*
Phylogeny	Isolation of bacteriocin-like substances producing bacteria from finished cattle-manure compost and activity evaluation against some food-borne pathogenic and spoilage bacteria.	Abdel-Mohsein H, Yamamoto N, Otawa K, Tada C, Nakai Y	J Gen Appl Microbiol	10.2323/jgam.56.151	2010	*
Pathogenicity	Cellular effects induced by Inula graveolens and Santolina corsica essential oils on Staphylococcus aureus.	Guinoiseau E, Luciani A, Rossi PG, Quilichini Y, Ternengo S, Bradesi P, Berti L	Eur J Clin Microbiol Infect Dis	10.1007/s10096-010-0943-x	2010	*
Pathogenicity	Lethal effect of chitosan-Ag (I) films on Staphylococcus aureus as evaluated by electron microscopy.	Diaz-Visurraga J, Garcia A, Cardenas G	J Appl Microbiol	10.1111/j.1365-2672.2009.04447.x	2009	*
Pathogenicity	Development and validation of a microbiological agar assay for determination of cefuroxime sodium in pharmaceutical preparations.	Schmidt CA, Agarrayua DA, Laporta LV, Machado JC, Manfio ML, Bittencourt CF	J Microbiol Methods	10.1016/j.mimet.2009.03.012	2009	*
Metabolism	No relationship exists between PBP 2a amounts expressed in different MRSA strains obtained clinically and their beta-lactam MIC values.	Parvez MA, Shibata H, Nakano T, Niimi S, Fujii N, Arakaki N, Higuti T	J Med Invest	10.2152/jmi.55.246	2008	*
Biotechnology	Interactions in dual species biofilms between Listeria monocytogenes EGD-e and several strains of Staphylococcus aureus.	Rieu A, Lemaitre JP, Guzzo J, Piveteau P	Int J Food Microbiol	10.1016/j.ijfoodmicro.2008.05.006	2008	*
Pathogenicity	Antibacterial activity of guava (Psidium guajava L.) and Neem (Azadirachta indica A. Juss.) extracts against foodborne pathogens and spoilage bacteria.	Mahfuzul Hoque MD, Bari ML, Inatsu Y, Juneja VK, Kawamoto S	Foodborne Pathog Dis	10.1089/fpd.2007.0040	2007	*
Pathogenicity	The mechanism of the bactericidal activity of hinokitiol.	Morita Y, Sakagami Y, Okabe T, Ohe T, Inamori Y, Ishida N	Biocontrol Sci	10.4265/bio.12.101	2007	*
Pathogenicity	Synthesis and biological properties of gemini quaternary ammonium compounds, 5,5'-[2,2'-(alpha,omega-polymethylnedicarbonyldioxy)diethyl]bis-(3-alkyl-4-methyl thiazolium iodide) and 5,5'-[2,2'-(p-phenylenedicarbonyldioxy)diethyl]bis(3-alkyl-4-methylthiazolium bromide).	Shirai A, Sumitomo T, Yoshida M, Kaimura T, Nagamune H, Maeda T, Kourai H	Chem Pharm Bull (Tokyo)	10.1248/cpb.54.639	2006	*
Pathogenicity	Multifactorial aspects of antimicrobial activity of propolis.	Scazzocchio F, D'Auria FD, Alessandrini D, Pantanella F	Microbiol Res	10.1016/j.micres.2005.12.003	2006	*
Pathogenicity	Studies on antimicrobial activity, in vitro, of Physalis angulata L. (Solanaceae) fraction and physalin B bringing out the importance of assay determination.	Silva MT, Simas SM, Batista TG, Cardarelli P, Tomassini TC	Mem Inst Oswaldo Cruz	10.1590/s0074-02762005000700018	2006	*
Pathogenicity	Phagocytic and bactericidal activity and morphological parameters of blood platelets in patients with Trichinella spiralis infection.	Matowicka-Karna J, Kemona H, Dymicka-Piekarska V, Butkiewicz A	Rocz Akad Med Bialymst		2005	*
Pathogenicity	Carbapenem-based prodrugs. Design, synthesis, and biological evaluation of carbapenems.	Hakimelahi GH, Moosavi-Movahedi AA, Saboury AA, Osetrov V, Khodarahmi GA, Shia KS	Eur J Med Chem	10.1016/j.ejmech.2004.11.002	2005	*
Pathogenicity	Microbiological assay for enrofloxacin injection.	e Souza MJ, Bittencourt CF, e Souza Filho Pda S	Int J Pharm	10.1016/j.ijpharm.2003.11.012	2004	*
Metabolism	Nonparallel secretion of antibacterial activity and protein in porcine pancreatic juice.	Holowachuk SA, Bal'a MF, Gerard PD, Buddington RK	Pancreas	10.1097/00006676-200403000-00017	2004	*
Pathogenicity	Diastereomeric selective effects for growth inhibition of synthesized mini parallel double-stranded peptides on Escherichia coli and Staphylococcus aureus.	Kobayashi S, Atuchi N, Kobayashi H, Shiraishi A, Hamashima H, Tanaka A	Chem Pharm Bull (Tokyo)	10.1248/cpb.52.204	2004	*
Pathogenicity	A kinetic microplate method for quantifying the antibacterial properties of biological fluids.	Holowachuk SA, Bal'a MF, Buddington RK	J Microbiol Methods	10.1016/s0167-7012(03)00190-8	2003	*
Pathogenicity	Application of the Barton photochemical reaction in the synthesis of 1-dethia-3-aza-1-carba-2-oxacephem: a novel agent against resistant pathogenic microorganisms.	Hakimelahi GH, Li PC, Moosavi-Movahedi AA, Chamani J, Khodarahmi GA, Ly TW, Valiyev F, Leong MK, Hakimelahi S, Shia KS, Chao I	Org Biomol Chem	10.1039/b304167k	2003	*
Enzymology	Purification and characterization of nitric oxide synthase from Staphylococcus aureus.	Hong IS, Kim YK, Choi WS, Seo DW, Yoon JW, Han JW, Lee HY, Lee HW	FEMS Microbiol Lett	10.1016/S0378-1097(03)00254-4	2003	*
Pathogenicity	Green-leaf-derived C6-aroma compounds with potent antibacterial action that act on both Gram-negative and Gram-positive bacteria.	Nakamura S, Hatanaka A	J Agric Food Chem	10.1021/jf025808c	2002	*
Pathogenicity	[The effect of the intra- and extracellular metabolites of microorganisms isolated from various ecotopes on the catalase activity of Staphylococcus aureus 6538P].	Bukharin OV, Sgibnev AV, Cherkasov SV, Ivanov IuB	Mikrobiologiia		2002	*
Pathogenicity	Comparison of the effects in vitro of tea tree oil and plaunotol on methicillin-susceptible and methicillin-resistant strains of Staphylococcus aureus.	Hada T, Furuse S, Matsumoto Y, Hamashima H, Masuda K, Shiojima K, Arai T, Sasatsu M	Microbios		2001	*
Phylogeny	Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids.	Scazzocchio F, Cometa MF, Tomassini L, Palmery M	Planta Med	10.1055/s-2001-16493	2001	*
Enzymology	Effects of Helichrysum italicum extract on growth and enzymatic activity of Staphylococcus aureus.	Nostro A, Bisignano G, Angela Cannatelli M, Crisafi G, Paola Germano M, Alonzo V	Int J Antimicrob Agents	10.1016/s0924-8579(01)00336-3	2001	*
Pathogenicity	Antimicrobial activity of selected non-antibiotics--activity of methotrexate against Staphylococcus aureus strains.	Kruszewska H, Zareba T, Tyski S	Acta Pol Pharm		2000	*
Pathogenicity	Design, synthesis, and SAR of novel carbapenem antibiotics with high stability to Xanthomonas maltophilia oxyiminocephalosporinase type II.	Hakimelahi GH, Moosavi-Movahedi AA, Tsay SC, Tsai FY, Wright JD, Dudev T, Hakimelahi S, Lim C	J Med Chem	10.1021/jm000213z	2000	*
Pathogenicity	In vitro antimicrobial properties of recombinant ASABF, an antimicrobial peptide isolated from the nematode Ascaris suum.	Zhang H, Yoshida S, Aizawa T, Murakami R, Suzuki M, Koganezawa N, Matsuura A, Miyazawa M, Kawano K, Nitta K, Kato Y	Antimicrob Agents Chemother	10.1128/AAC.44.10.2701-2705.2000	2000	*
Cultivation	Modeling the aerobic growth and decline of Staphylococcus aureus as affected by pH and potassium sorbate concentration.	Giannuzzi L, Contreras E, Zaritzky N	J Food Prot	10.4315/0362-028x-62.4.356	1999	*
Pathogenicity	Feasibility of an in vitro microbiological model as an alternative to the rabbit eye model.	Devarajan PV, Bhogte CP, Majali AB, Sabharwal S	Drug Dev Ind Pharm	10.1081/ddc-100102238	1999	*
Pathogenicity	[In vitro specific binding of Shiga toxin 1 and 2 by TAK-751S (Gb3 analog)].	Takeda T, Yoshino K, Adachi E, Yamagata K, Uchida H, Okonogi K, Iizawa Y	Kansenshogaku Zasshi	10.11150/kansenshogakuzasshi1970.72.924	1998	*
Metabolism	[Increase of non-amidated muropeptides in the cell wall of vancomycin-resistant Staphylococcus aureus (VRSA) strain Mu50].	Hanaki H, Labischinski H, Inaba Y, Hiramatsu K	Jpn J Antibiot		1998	*
Metabolism	[Mechanism of vancomycin resistance in MRSA strain Mu50].	Hanaki H, Labischinski H, Sasaki K, Kuwahara-Arai K, Inaba Y, Hiramatsu K	Jpn J Antibiot		1998	*
Pathogenicity	Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.	Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I	Lancet	10.1016/S0140-6736(97)07324-8	1997	*
Pathogenicity	[Evaluation of reduced vancomycin susceptibility of MRSA strain Mu50 with various conditions of antibiotic susceptibility tests].	Hanaki H, Hiramatsu K	Jpn J Antibiot		1997	*
Pathogenicity	Cephalosporin 3'-phloroglucide esters and 7-(phloroglucidamido) cephalosporins as novel antibacterial agents.	Hwu JR, Moshfegh AA, Tsay SC, Lin CC, Tseng WN, Azaripour A, Mottaghian H, Hakimelahi GH	J Med Chem	10.1021/jm960810e	1997	*
Enzymology	Identification of nitric oxide synthase in Staphylococcus aureus.	Choi WS, Chang MS, Han JW, Hong SY, Lee HW	Biochem Biophys Res Commun	10.1006/bbrc.1997.7189	1997	*
Phylogeny	Isolation and characterization of autolysin-defective mutants of Staphylococcus aureus that form cell packets.	Kaneda S	Curr Microbiol	10.1007/s002849900195	1997	*
Pathogenicity	Prevention of infection in dental procedures.	Matsuyama M, Usami T, Masuda K, Niimi N, Ohta M, Ueda M	J Hosp Infect	10.1016/s0195-6701(97)90164-x	1997	*
Pathogenicity	Synthesis and biological evaluation of an electronically activated isooxacephem.	Hakimelahi GH, Tsay SC, Tso HH, Ramezani Z, Hwu JR	Bioorg Med Chem	10.1016/0968-0896(96)00131-9	1996	*
Metabolism	Binding affinities of beta-lactam antibodies for penicillin-binding protein 2' in methicillin-resistant staphylococcus aureus.	Sumita Y, Fukasawa M, Mitsuhashi S, Inoue M	J Antimicrob Chemother	10.1093/jac/35.4.473	1995	*
Enzymology	Identification of endo-beta-N-acetylglucosaminidase and N-acetylmuramyl-L-alanine amidase as cluster-dispersing enzymes in Staphylococcus aureus.	Sugai M, Komatsuzawa H, Akiyama T, Hong YM, Oshida T, Miyake Y, Yamaguchi T, Suginaka H	J Bacteriol	10.1128/jb.177.6.1491-1496.1995	1995	*
Enzymology	Alteration of bacteriolytic enzyme profile of Staphylococcus aureus during growth.	Komatsuzawa H, Sugai M, Nakashima S, Suginaka H	Microbiol Immunol	10.1111/j.1348-0421.1995.tb02253.x	1995	*
Pathogenicity	Bacteriological evaluation of a new air turbine handpiece for preventing cross-contamination in dental procedures.	Masuda K, Ohta M, Ohsuka S, Matsuyama M, Ashoori M, Usami T, Ito M, Ueda M, Kaneda T	Nagoya J Med Sci		1994	*
Pathogenicity	Effect of hydrocortisone treatment on oxygen metabolism and phagocytosis of peripheral blood neutrophils in asthmatic patients, sensitive and resistant to glucocorticosteroid therapy.	Jankowska R, Zak-Nejmark T, Malolepszy J, Nadobna G, Osos M, Medrala W	Arch Immunol Ther Exp (Warsz)		1994	*
Phylogeny	Isolation and characterization of Staphylococcus aureus mutants which form altered cell clusters.	Sugai M, Komatsuzawa H, Ooku-Inomata K, Miyake Y, Ishida E, Suginaka H	Microbiol Immunol	10.1111/j.1348-0421.1994.tb02158.x	1994	*
Metabolism	[The interaction of staphylococci with plasmin and its inhibitors].	Zorin NA, Zhabin SG, Vorob'eva ON	Zh Mikrobiol Epidemiol Immunobiol		1993	*
Cultivation	[Modeling of the bactericidal effect of spiramycin. Choice of a pharmacodynamic model].	Renard L, Sanders P, Laurentie M	Vet Res		1993	*
Cultivation	[The effect of culture media on bacteriocin production in various strains of bacteria].	Laukova A	Vet Med (Praha)		1992	*
Pathogenicity	[Evaluation of phagocytic activity of peripheral blood neutrophils in patients after kidney transplantation treated with cyclosporin and prednisone or with azathioprine with prednisone].	Hrycek A, Szoltysik I	Acta Haematol Pol		1992	*
Pathogenicity	[The effect of the antibiotic AL-87 on the amino acid yield from Staphylococcus aureus 209P cells].	Snirnov VV, Churkina LN, Kiprianova EA, Pustovalova LI	Mikrobiol Zh		1991	*
Pathogenicity	Suppression of penicillin-induced lysis of Staphylococcus aureus by cibacron blue 3G-A.	Sugai M, Ooku K, Akiyama T, Inoue S, Iseda S, Miyake Y, Suginaka H	FEMS Microbiol Lett	10.1016/0378-1097(91)90586-y	1991	*
Pathogenicity	[The action of tomicide on macromolecular synthesis in bacterial cells].	Butova LG, Blinkova LP	Zh Mikrobiol Epidemiol Immunobiol		1991	*
Phylogeny	Expression of penicillin G acylase gene from Bacillus megaterium ATCC 14945 in Escherichia coli and Bacillus subtilis.	Kang JH, Hwang Y, Yoo OJ	J Biotechnol	10.1016/0168-1656(91)90001-c	1991	*
Pathogenicity	Effects of antibiotics on nonopsonized adherence of Staphylococcus aureus to human polymorphonuclear leukocytes.	Kohada A, Miyake Y, Sugai M, Tsuru H, Suginaka H	Chemotherapy	10.1159/000238832	1991	*
Enzymology	[Hydrolysis of a Staphylococcus aureus cell wall peptidoglycan by 209 P lysoamidase].	Severin AI, Il'chenko VIa, Kulaev IS	Biokhimiia		1990	*
Pathogenicity	The effect of zinc oxide on Staphylococcus aureus and polymorphonuclear cells in a tissue cage model.	Sunzel B, Lasek J, Soderberg T, Elmros T, Hallmans G, Holm S	Scand J Plast Reconstr Surg Hand Surg	10.3109/02844319009004517	1990	*
Enzymology	[Determination of the enterotoxigenicity of conditionally pathogenic microorganisms using the method of suppressing the dehydrogenase activity of the UV mutant Staphylococcus aureus 209 P].	Kalinina TE, Ternovskaia LN, Andrusenko IT, Kaminskaia VP, Ved'mina EA, Shepelev AP	Lab Delo		1990	*
Pathogenicity	Comparison of electronic and viability counting methods for determination of postantibiotic effect of oxacillin on Staphylococcus aureus.	Nadler HL, Curby WA, Forgacs P, Rosenberg F	Antimicrob Agents Chemother	10.1128/AAC.33.12.2155	1989	*
Enzymology	Purification of a 51 kDa endo-beta-N-acetylglucosaminidase from Staphylococcus aureus.	Sugai M, Koike H, Hong YM, Miyake Y, Nogami R, Suginaka H	FEMS Microbiol Lett	10.1016/0378-1097(89)90209-7	1989	*
Pathogenicity	[Production of oxygen free radicals by phagocytes in patients on hemodialysis].	Ueda Y	Kansenshogaku Zasshi	10.11150/kansenshogakuzasshi1970.63.997	1989	*
Pathogenicity	Aminoglycosides enhance the adherence of Staphylococcus aureus to HeLa cells.	Miyake Y, Kohada A, Fujii I, Sugai M, Suginaka H	J Antimicrob Chemother	10.1093/jac/23.1.79	1989	*
Pathogenicity	[A stat-method of determining antibiotic concentration in biological fluids].	Pasternak NA, Shenderovich VA, Ved'mina EA	Lab Delo		1989	*
Pathogenicity	[Influence of human albumin on bactericidal or antibacterial activities of cephems and monobactams].	Saionji K	Jpn J Antibiot		1988	*
Enzymology	DNA gyrase of Staphylococcus aureus and inhibitory effect of quinolones on its activity.	Takahata M, Nishino T	Antimicrob Agents Chemother	10.1128/AAC.32.8.1192	1988	*
Pathogenicity	Effects of mucopolysaccharides on penicillin-induced lysis of Staphylococcus aureus.	Kiriyama T, Miyake Y, Sugai M, Kobayashi K, Yoshiga K, Takada K, Suginaka H	J Med Microbiol	10.1099/00222615-24-4-325	1987	*
Pathogenicity	Synthesis of delta 3-1-methylene-1-carbacephems.	Herdewijn P, Claes PJ, Vanderhaeghe H	J Med Chem	10.1021/jm00155a013	1986	*
Pathogenicity	Phagocytic and bactericidal activities of neutrophils in duodenal ulcer patients during cimetidine treatment.	Markiewicz K, Kowalska M, Malec P, Denys A	Arch Immunol Ther Exp (Warsz)		1985	*
Pathogenicity	[Fatty acid composition of variant Staphylococcus aureus 209 P resistant to antibiotic AL-87].	Smirnov VV, Churkina LN, Vasiurenko ZP, Kiprianova EA, Garagulia AD	Antibiotiki		1984	*
Pathogenicity	[Antifungal and antimicrobial activity of beta-ionone and vitamin A derivatives].	Mikhlin ED, Radina VP, Dmitrovskii AA, Blinkova LP, Butova LG	Prikl Biokhim Mikrobiol		1983	*
Enzymology	[Action of dioxidine on the membrane apparatus of the bacterial cell].	Rudzit EA, Ermachenko VA, Kutsemako RT, Dzhemukhadze GK, Kharat'ian EF	Prikl Biokhim Mikrobiol		1983	*
Pathogenicity	[Model UF-2 mutant of Staphylococcus aureus 209 P for titrating Vibrio cholera enterotoxin].	Pasternak NA, Ved'mina EA, Andrusenko IT, Shenderovich VA, Zhuravleva TP	Zh Mikrobiol Epidemiol Immunobiol		1983	*
Enzymology	Production, purification, and properties of a bacteriocin from Staphylococcus aureus isolated from saliva.	Nakamura T, Yamazaki N, Taniguchi H, Fujimura S	Infect Immun	10.1128/iai.39.2.609-614.1983	1983	*
Enzymology	Synthesis of N-(2-hydroxypropyl)methacrylamide copolymers with antimicrobial activity.	Solovskij MV, Ulbrich K, Kopecek J	Biomaterials	10.1016/0142-9612(83)90069-8	1983	*
Pathogenicity	New rapid assay for nafcillin in serum by spectrofluorometry.	Lichtenwalner DM, Suh B, Lorber B, Sugar AM	Antimicrob Agents Chemother	10.1128/AAC.16.2.210	1979	*
Pathogenicity	Prevention of penicillin-induced lysis of Staphylococcus aureus by cellular lipoteichoic acid.	Suginaka H, Shimatani M, Ogawa M, Kotani S	J Antibiot (Tokyo)	10.7164/antibiotics.32.73	1979	*
Pathogenicity	Biological properties and clinical application of propolis. III. Investigation of the sensitivity of Staphylococci isolated from pathological cases to ethanol extract of propolis (EEP). Attempts on inducing resistance in laboratory Staphylococcus strain to EEP.	Scheller S, Tustanowski J, Kurylo B, Paradowski Z, Obuszko Z	Arzneimittelforschung		1977	*
Metabolism	Studies on bacterial cell wall inhibitors. III. 3-amino-3-deoxy-D-glucose, an inhibitor of bacterial cell wall synthesis.	Iwai Y, Tanaka H, Oiwa R, Shimizu S, Omura S	Biochim Biophys Acta	10.1016/0304-4165(77)90102-7	1977	*
Metabolism	Microorganism capable of decomposing N-acetylglucosaminyl ribitol teichoic acid of Staphylococcus aureus.	Iwata S, Tochikubo K, Kato K, Hirata T, Kotani S, Yagi K	Jpn J Microbiol	10.1111/j.1348-0421.1976.tb00918.x	1976	*
Phylogeny	Identification of producer and biological activities of new antibiotics, mimosamycin and chlorocarcins.	Mikami Y, Yokoyama K, Omi A, Arai T	J Antibiot (Tokyo)	10.7164/antibiotics.29.408	1976	*
Enzymology	Immunoadjuvant activities of peptidoglycan subunits from the cell walls of Staphyloccus aureus and Lactobacillus plantarum.	Kotani S, Watanabe Y, Shimono T, Kinoshita F, Narita T	Biken J		1975	*
Enzymology	Cellular location of degradative enzymes in Staphylococcus aureus.	Nugent KM, Huff E, Cole RM, Theodore TS	J Bacteriol	10.1128/jb.120.3.1012-1016.1974	1974	*
Enzymology	Lipoteichoic acid localization in mesosomal vesicles of Staphylococcus aureus.	Huff E, Cole RM, Theodore TS	J Bacteriol	10.1128/jb.120.1.273-281.1974	1974	*
Enzymology	Protein and fatty acid composition of mesosomal vesicles and plasma membranes of Staphylococcus aureus.	Theodore TS, Panos C	J Bacteriol	10.1128/jb.116.2.571-576.1973	1973	*
Pathogenicity	Four-hour microbiological assay of gentamicin in serum.	Warren E, Snyder RJ, Washington JA II	Antimicrob Agents Chemother	10.1128/AAC.1.1.46	1972	*
Enzymology	Electron microscopy during release and purification of mesosomal vesicles and protoplast membranes from Staphylococcus aureus.	Popkin TJ, Theodore TS, Cole RM	J Bacteriol	10.1128/jb.107.3.907-917.1971	1971	*
Pathogenicity	Lysostaphin-induced, osmotically fragile Staphylococcus aureus cells.	Huber TW, Schuhardt VT	J Bacteriol	10.1128/jb.103.1.116-119.1970	1970	*
Pathogenicity	Electron microscopy and viability of lysostaphin-induced staphylococcal spheroplasts, protoplast-like bodies, and protoplasts.	Schuhardt VT, Huber TW, Pope LM	J Bacteriol	10.1128/jb.97.1.396-401.1969	1969	*
Pathogenicity	Osmotic fragility and viability of lysostaphin-induced staphylococcal spheroplasts.	Schuhardt VT, Klesius PH	J Bacteriol	10.1128/jb.96.3.734-737.1968	1968	*
Pathogenicity	Differential chromatographic bioassay for the gentamicin complex.	Wagman GH, Oden EM, Weinstein MJ	Appl Microbiol	10.1128/am.16.4.624-627.1968	1968	*
Pathogenicity	Antibiotic sensitivity of Micrococcus radiodurans.	Hawiger J, Jeljaszewicz J	Appl Microbiol	10.1128/am.15.2.304-306.1967	1967	*
Phylogeny	In Silico Study for Algerian Essential Oils as Antimicrobial Agents against Multidrug-Resistant Bacteria Isolated from Pus Samples.	Aouf A, Bouaouina S, Abdelgawad MA, Abourehab MAS, Farouk A	Antibiotics (Basel)	10.3390/antibiotics11101317	2022	*
	Development of structurally extended benzosiloxaboroles - synthesis and in vitro biological evaluation.	Pacholak P, Krajewska J, Winska P, Dunikowska J, Gogowska U, Mierzejewska J, Durka K, Wozniak K, Laudy AE, Lulinski S	RSC Adv	10.1039/d1ra04127d	2021	*
	Probiotic Effects and Metabolic Products of Enterococcus faecalis LD33 with Respiration Capacity.	Jiao Y, Yang H, Shigwedha N, Zhang S, Liu F, Zhang L	Foods	10.3390/foods11040606	2022	*
	Anti-Biofilm Effects of Torilis japonica Ethanol Extracts against Staphylococcus aureus.	Kim GS, Park CR, Kim JE, Kim HK, Kim BS	J Microbiol Biotechnol	10.4014/jmb.2107.07053	2022	*
	The Ethyl Acetate Extract of the Marine Edible Gastropod Haliotis tuberculata coccinea: a Potential Source of Bioactive Compounds.	Tortorella E, Giugliano R, De Troch M, Vlaeminck B, de Vicose GC, de Pascale D	Mar Biotechnol (NY)	10.1007/s10126-021-10073-0	2021	*
	Bacteriostatic impact of nanoscale zero-valent iron against pathogenic bacteria in the municipal wastewater.	Sadek AH, Asker MS, Abdelhamid SA	Biologia (Bratisl)	10.1007/s11756-021-00814-w	2021	*
	Synthesis and Effect of Hierarchically Structured Ag-ZnO Hybrid on the Surface Antibacterial Activity of a Propylene-Based Elastomer Blends.	Bazant P, Sedlacek T, Kuritka I, Podlipny D, Holcapkova P	Materials (Basel)	10.3390/ma11030363	2018	*
	The application of alkaline and acidic electrolyzed water in the sterilization of chicken breasts and beef liver.	Shimamura Y, Shinke M, Hiraishi M, Tsuchiya Y, Masuda S	Food Sci Nutr	10.1002/fsn3.305	2015	*
	Synthesis, characterization, optical and antimicrobial studies of polyvinyl alcohol-silver nanocomposites.	Mahmoud KH	Spectrochim Acta A Mol Biomol Spectrosc	10.1016/j.saa.2014.11.074	2014	*
	Interaction of iodine with 2-hydroxypropyl-alpha-cyclodextrin and its bactericidal activity.	Tomono K, Goto H, Suzuki T, Ueda H, Nagai T, Watanabe J	Drug Dev Ind Pharm	10.1081/ddc-120015359	2002	*
	Identification and semiquantitative estimation of antibiotics added to complete feeds, premixes, and concentrates.	Gafner JL	J AOAC Int		1999	*
	Effect of chitosan in meat preservation.	Darmadji P, Izumimoto M	Meat Sci	10.1016/0309-1740(94)90114-7	1994	*
	Influence of carrier-specific, thymus-derived cells on the immunologlobulin M antibody response to staphylococcal lipoteichoic acid.	Beining PR, Flannery GM, Prescott B, Baker PJ	Infect Immun	10.1128/iai.29.1.132-139.1980	1980	*
	Effect of immunization of guinea pigs on in vitro phagocytosis by polymorphonuclear leukocytes (PMNL).	Tchorzewski H, Denys A, Grzybowski A, Malewska Z	Arch Immunol Ther Exp (Warsz)		1980	*
	Structural requirements for arthritogenicity of peptidoglycans from Staphylococcus aureus and Lactobacillus plant arum and analogous synthetic compounds.	Kohashi O, Pearson CM, Watanabe Y, Kotani S, Koga T	J Immunol		1976	*
	Phagocytic properties of exudative microphages from animals with alloxan diabetes and insulin-induced hypoglycemia.	Danieluk-Gil I	Arch Immunol Ther Exp (Warsz)		1975	*
	Characterization of the lipids of mesosomal vesicles and plasma membranes from Staphylococcus aureus.	Beining PR, Huff E, Prescott B, Theodore TS	J Bacteriol	10.1128/jb.121.1.137-143.1975	1975	*
	Enhancement of antibiotic activity against Staphylococcus aureus by exposure to hyperbaric oxygen.	Bornside GH	Appl Microbiol	10.1128/am.15.5.1020-1024.1967	1967	*
	Apis mellifera Venom Inhibits Bacterial and Fungal Pathogens in vitro.	K Bakhiet E, A M Hussien H, Elshehaby M	Pak J Biol Sci	10.3923/pjbs.2022.875.884	2022	*
	Oxazoline scaffold in synthesis of benzosiloxaboroles and related ring-expanded heterocycles: diverse reactivity, structural peculiarities and antimicrobial activity.	Krajewska J, Nowicki K, Durka K, Marek-Urban PH, Winska P, Stepniewski T, Wozniak K, Laudy AE, Lulinski S	RSC Adv	10.1039/d2ra03910a	2022	*

References

#139	Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 346

#20215

Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )

#41865 ; Curators of the CIP;

#66792

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#67770 Japan Collection of Microorganism (JCM) ; Curators of the JCM;

#68375

Automatically annotated from API ID32STA .

#68382

Automatically annotated from API zym .

#69479

João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta .

#69480

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#69481

Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch: Predictions based on the model GenomeNet Sporulation v. 1 . ( DOI 10.21203/rs.3.rs-2527258/v1 )

#83588

Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.: StrainInfo: A central database for resolving microbial strain identifiers . ( DOI 10.60712/SI-ID4992.1 )

#116632 Collection of Institut Pasteur ; Curators of the CIP; CIP 53.156
* These data were automatically processed and therefore are not curated

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Search for species Staphylococcus aureus in external resources:
SILVA
BRENDA
PANGAEA
StrainInfo
GBIF

Staphylococcus aureus subsp. aureus JCM 2151

Staphylococcus aureus strain NCTC7447

Change proposal

Change proposal